Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing.
|
Nat Genet
|
2007
|
9.47
|
2
|
Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells.
|
Cell Stem Cell
|
2009
|
8.97
|
3
|
HIF-dependent antitumorigenic effect of antioxidants in vivo.
|
Cancer Cell
|
2007
|
4.81
|
4
|
Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders.
|
Blood
|
2009
|
4.22
|
5
|
Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures.
|
Cell Res
|
2011
|
3.58
|
6
|
Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes.
|
Stem Cells
|
2010
|
3.53
|
7
|
Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease.
|
Blood
|
2011
|
3.43
|
8
|
Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting.
|
Blood
|
2011
|
3.21
|
9
|
Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts.
|
Stem Cells
|
2008
|
3.14
|
10
|
Defining the role of Wnt/beta-catenin signaling in the survival, proliferation, and self-renewal of human embryonic stem cells.
|
Stem Cells
|
2005
|
2.81
|
11
|
RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells.
|
Blood
|
2013
|
2.00
|
12
|
In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells.
|
Proc Natl Acad Sci U S A
|
2008
|
1.99
|
13
|
Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells.
|
Mol Ther
|
2003
|
1.87
|
14
|
Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions.
|
Stem Cells
|
2010
|
1.74
|
15
|
HES1 inhibits cycling of hematopoietic progenitor cells via DNA binding.
|
Stem Cells
|
2006
|
1.66
|
16
|
Promoting human embryonic stem cell renewal or differentiation by modulating Wnt signal and culture conditions.
|
Cell Res
|
2007
|
1.61
|
17
|
Notch signaling activation in human embryonic stem cells is required for embryonic, but not trophoblastic, lineage commitment.
|
Cell Stem Cell
|
2008
|
1.60
|
18
|
Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood.
|
Blood
|
2011
|
1.59
|
19
|
PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
|
Prostate
|
2006
|
1.55
|
20
|
The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?
|
Cancer Res
|
2008
|
1.43
|
21
|
Functional antigen-presenting leucocytes derived from human embryonic stem cells in vitro.
|
Lancet
|
2004
|
1.42
|
22
|
The phenotype of a germline mutation in PIGA: the gene somatically mutated in paroxysmal nocturnal hemoglobinuria.
|
Am J Hum Genet
|
2012
|
1.40
|
23
|
Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice.
|
Exp Hematol
|
2003
|
1.35
|
24
|
Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells.
|
Blood
|
2011
|
1.34
|
25
|
Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells.
|
Blood
|
2002
|
1.33
|
26
|
Trophoblast differentiation defect in human embryonic stem cells lacking PIG-A and GPI-anchored cell-surface proteins.
|
Cell Stem Cell
|
2008
|
1.32
|
27
|
Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression.
|
Nat Protoc
|
2012
|
1.32
|
28
|
Dissection of the c-Kit signaling pathway in mouse primordial germ cells by retroviral-mediated gene transfer.
|
Proc Natl Acad Sci U S A
|
2002
|
1.26
|
29
|
Combinatorial signals of activin/nodal and bone morphogenic protein regulate the early lineage segregation of human embryonic stem cells.
|
J Biol Chem
|
2008
|
1.26
|
30
|
Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cells.
|
Cancer Res
|
2010
|
1.24
|
31
|
Integrated biochemical and mechanical signals regulate multifaceted human embryonic stem cell functions.
|
J Cell Biol
|
2010
|
1.22
|
32
|
Myocyte enhancer factor 2 mediates calcium-dependent transcription of the interleukin-2 gene in T lymphocytes: a calcium signaling module that is distinct from but collaborates with the nuclear factor of activated T cells (NFAT).
|
J Biol Chem
|
2004
|
1.20
|
33
|
Inducible and reversible transgene expression in human stem cells after efficient and stable gene transfer.
|
Stem Cells
|
2006
|
1.20
|
34
|
Self-organized vascular networks from human pluripotent stem cells in a synthetic matrix.
|
Proc Natl Acad Sci U S A
|
2013
|
1.18
|
35
|
Electrophysiological properties of pluripotent human and mouse embryonic stem cells.
|
Stem Cells
|
2005
|
1.17
|
36
|
FLT3/ITD expression increases expansion, survival and entry into cell cycle of human haematopoietic stem/progenitor cells.
|
Br J Haematol
|
2007
|
1.12
|
37
|
Radiofrequency-enhanced vascular gene transduction and expression for intravascular MR imaging-guided therapy: feasibility study in pigs.
|
Radiology
|
2005
|
1.10
|
38
|
Lentivirus-mediated gene transfer and expression in established human tumor antigen-specific cytotoxic T cells and primary unstimulated T cells.
|
Hum Gene Ther
|
2003
|
1.09
|
39
|
The differential formation of the LINC-mediated perinuclear actin cap in pluripotent and somatic cells.
|
PLoS One
|
2012
|
1.09
|
40
|
Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation.
|
Stem Cells
|
2015
|
1.07
|
41
|
An improved method for generating and identifying human induced pluripotent stem cells.
|
Methods Mol Biol
|
2010
|
1.07
|
42
|
TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice.
|
Cancer Res
|
2002
|
1.06
|
43
|
Expanded activity of dimer nucleases by combining ZFN and TALEN for genome editing.
|
Sci Rep
|
2013
|
1.06
|
44
|
Antitumor activity of the histone deacetylase inhibitor MS-275 in prostate cancer models.
|
Prostate
|
2007
|
1.05
|
45
|
Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions.
|
Stem Cell Res
|
2013
|
1.02
|
46
|
Serial imaging of human embryonic stem-cell engraftment and teratoma formation in live mouse models.
|
Cell Res
|
2009
|
1.02
|
47
|
Immunotherapy of established tumors using bone marrow transplantation with antigen gene--modified hematopoietic stem cells.
|
Nat Med
|
2003
|
1.00
|
48
|
In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC).
|
Cancer Immunol Immunother
|
2008
|
0.99
|
49
|
Glycosylphosphatidylinositol-anchored protein deficiency confers resistance to apoptosis in PNH.
|
Exp Hematol
|
2008
|
0.96
|
50
|
Targeted correction of RUNX1 mutation in FPD patient-specific induced pluripotent stem cells rescues megakaryopoietic defects.
|
Blood
|
2014
|
0.95
|
51
|
Molecular imaging and stem cell research.
|
Mol Imaging
|
2011
|
0.95
|
52
|
Human induced pluripotent stem cell-derived mesenchymal stem cell seeding on calcium phosphate scaffold for bone regeneration.
|
Tissue Eng Part A
|
2014
|
0.94
|
53
|
Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation.
|
Blood
|
2005
|
0.93
|
54
|
How reproducible is bioluminescent imaging of tumor cell growth? Single time point versus the dynamic measurement approach.
|
Mol Imaging
|
2007
|
0.93
|
55
|
Stimulation of somatic cell reprogramming by ERas-Akt-FoxO1 signaling axis.
|
Stem Cells
|
2014
|
0.91
|
56
|
Ethics: China already has clear stem-cell guidelines.
|
Nature
|
2006
|
0.91
|
57
|
Promise and challenges of human iPSC-based hematologic disease modeling and treatment.
|
Int J Hematol
|
2012
|
0.91
|
58
|
Concise review: Human cell engineering: cellular reprogramming and genome editing.
|
Stem Cells
|
2012
|
0.90
|
59
|
Acceleration of G(1) cooperates with core binding factor beta-smooth muscle myosin heavy chain to induce acute leukemia in mice.
|
Cancer Res
|
2002
|
0.88
|
60
|
Efficient derivation and genetic modifications of human pluripotent stem cells on engineered human feeder cell lines.
|
Stem Cells Dev
|
2012
|
0.88
|
61
|
Early frameshift mutation in PIGA identified in a large XLID family without neonatal lethality.
|
Hum Mutat
|
2014
|
0.87
|
62
|
In vivo retroviral gene transfer by direct intrafemoral injection results in correction of the SCID phenotype in Jak3 knock-out animals.
|
Blood
|
2003
|
0.87
|
63
|
Transduction of donor hematopoietic stem-progenitor cells with Fas ligand enhanced short-term engraftment in a murine model of allogeneic bone marrow transplantation.
|
Blood
|
2002
|
0.86
|
64
|
Culture of human embryonic stem cells on human and mouse feeder cells.
|
Methods Mol Biol
|
2006
|
0.86
|
65
|
High-efficiency stable gene transduction in primary human melanocytes using a lentiviral expression system.
|
J Invest Dermatol
|
2004
|
0.84
|
66
|
The dazzle in germ cell differentiation.
|
J Mol Cell Biol
|
2009
|
0.84
|
67
|
Detection of dual-gene expression in arteries using an optical imaging method.
|
J Biomed Opt
|
2004
|
0.83
|
68
|
Differential sensitivity to JAK inhibitory drugs by isogenic human erythroblasts and hematopoietic progenitors generated from patient-specific induced pluripotent stem cells.
|
Stem Cells
|
2014
|
0.83
|
69
|
Lentiviral gene transduction of mouse and human stem cells.
|
Methods Mol Biol
|
2008
|
0.83
|
70
|
Potential of human induced pluripotent stem cells derived from blood and other postnatal cell types.
|
Regen Med
|
2010
|
0.83
|
71
|
Generation of glycosylphosphatidylinositol anchor protein-deficient blood cells from human induced pluripotent stem cells.
|
Stem Cells Transl Med
|
2013
|
0.79
|
72
|
Concise review: stem cell-based approaches to red blood cell production for transfusion.
|
Stem Cells Transl Med
|
2013
|
0.79
|
73
|
Efficient and scalable expansion of human pluripotent stem cells under clinically compliant settings: a view in 2013.
|
Ann Biomed Eng
|
2013
|
0.79
|
74
|
Multiple, interconvertible states of human pluripotent stem cells.
|
Cell Stem Cell
|
2010
|
0.79
|
75
|
And then there were none: no need for pluripotency factors to induce reprogramming.
|
Cell Stem Cell
|
2013
|
0.78
|
76
|
Generation and homing of iPSC-derived hematopoietic cells in vivo.
|
Mol Ther
|
2013
|
0.78
|
77
|
Double knockouts in human embryonic stem cells.
|
Cell Res
|
2010
|
0.77
|
78
|
Response: the role of RUNX1 isoforms in hematopoietic commitment of human pluripotent stem cells.
|
Blood
|
2013
|
0.75
|
79
|
Making lentiviral vectors more powerful and universal.
|
Discov Med
|
2003
|
0.75
|